Companies

Venn Life Sciences Holdings

Overview

Clinical research organisation Venn Life Sciences Holdings plans to be a consolidator in the European clinical research market. Venn moved from ISDX to Aim following the reversal of the Venn business into Armscote in return for 9.6m shares at 30p each. A placing at 30p a share raised £2.5m (£2.05m net) for the company, while shareholders who swapped their stake in the core business for shares in the quoted company raised £460,000. Venn was valued at £6m at the placing price.

Sector: Health

News blog

• Venn Life Sciences Holdings Posted: 18/05/2014
• Venn Life Sciences Holdings Posted: 04/11/2013
• Venn Life Sciences Holdings Posted: 17/12/2012

Browse by sector

All companies

• Aim advisers
• Aim Awards
• Aim investor relations
• Cleantech
• Construction
• Consumer
• Electricals
• Financial
• Food
• Health
• Industrial
• Leisure
• Media
• Mobile
• Property
• QUOTED MICRO
• Resources
• Retail
• Security
• Services
• Technology
• Telecoms
• Training
• Transport

• 2.4mNumber of messages posted on SocialGo networks
  
• $38mCost savings generated by ideas from WalMart staff over a two month period